Development of a Commercial Process for Deucravacitinib, a Deuterated API for TYK2 Inhibition

• DOI: 10.1021/acs.oprd.1c00468
• Publication Date: 2022-02-17T20:46:38Z
• Authors: Daniel S. Treitler; Maxime C. Soumeil...; Eric M. Simmons; Dong Lin; Bahar Inankur; Amanda J. Rogers; Michael Dummeldinger; Sergei Kolotuchin; Collin Chan; Jun Li; Adam Freitag; Federico Lora Gon...; Michael J. Smith; Chris Sfouggatakis; Jianji Wang; Tamas Benkovics; Joerg Deerberg; James H. Simpson; Ke Chen; Steven Tymonko
• Keywords: 01 natural sciences; 0104 chemical sciences